Rarecells Announces New Clinical Data Showing Superior Sensitivity and Tumor Heterogeneity Detection by Synergistic Combination of ctDNA and ISET® CTC-DNA in Patients with Early-Stage Lung Cancer
Vanity Fair Italy Interviews Rarecells Founder Dr. Patrizia Paterlini
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors
Press Release: Rarecells announces Appointment of New Director to the Board